The placebo (I shall please) - Is it so pleasing in children?

Paediatric Anaesthesia

Volumn 15, Issue 10, 2005, Pages 809-813

  Anderson, Brian ^a   Cranswick, Noel ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHLORAMPHENICOL; CISAPRIDE; DIETHYLENE GLYCOL; DIPHTHERIA TOXOID; PLACEBO; PROPOFOL; SULFANILAMIDE; SURFACTANT; THALIDOMIDE;

CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG LEGISLATION; DRUG SAFETY; EDITORIAL; EXTRACORPOREAL CIRCULATION; HUMAN; INFORMED CONSENT; MEDICATION ERROR; OFF LABEL DRUG USE; PAIN; PEDIATRIC ANESTHESIA; PLACEBO CONTROLLED TRIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK BENEFIT ANALYSIS; UNITED KINGDOM; UNITED STATES; VEIN PUNCTURE; CHILD; DRUG CONTAMINATION; ETHICS; PEDIATRICS; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

CHILD; CHILD, PRESCHOOL; DRUG CONTAMINATION; HUMANS; PEDIATRICS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS;

EID: 33644681194     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2005.01732.x     Document Type: Editorial

References (46)

1. Lim A, Cranswick NE. Clinical trials, ethical issues and patient recruitment: an Australian perspective. Paediatr Perinat Drug Ther 2003 5: 183 187.
2. Impicciatore P, Choonara I. Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use. Br J Clin Pharmacol 1999 48: 15 18.
3. Kauffman RE. Status of drug approval processes and regulation of medications for children. Curr Opin Pediatr 1995 7: 195 198.
4. Fisk NM, Shennan AH. Litigation and prescribing drugs for unlicensed indications. Lancet 1993 341: 1218.
5. Blum RS. Legal considerations in off-label medication prescribing. Arch Intern Med 2002 162: 1777 1779.
6. Binstock W, Rubin R, Bachman C et al. The effect of premedication with OTFC, with or without ondansetron, on postoperative agitation, and nausea and vomiting in pediatric ambulatory patients. Pediatr Anesth 2004 14: 759 767.
7. Sheeran PW, Rose JB, Fazi LM et al. Rofecoxib administration to pediatric patients undergoing adenotonsillectomy. Pediatr Anesth 2004 14: 579 583.
8. Kararmaz A, Kaya S, Turhanoglu S et al. Oral ketamine premedication can prevent emergence agitation in children after desflurane anaesthesia. Pediatr Anesth 2004 14: 477 482.
9. Golparvar M, Saghaei M, Sajedi P et al. Paradoxical reaction following intravenous midazolam premedication in pediatric patients - a randomized placebo controlled trial of ketamine for rapid tranquilization. Pediatr Anesth 2004 14: 924 930.
10. World Medical Association (WMA). World Medical Association Declaration (WMA) of Helsinki. 1996.
11. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994 331: 394 398.
12. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med 2000 133: 455 463.
13. Ellenberg SS, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. Ann Intern Med 2000 133: 464 470.
14. Simon R. Are placebo-controlled clinical trials ethical or needed when alternative treatment exists Ann Intern Med 2000 133: 474 475.
15. Citron ML. Placebos and principles: a trial of ondansetron. Ann Intern Med 1993 118: 470 471.
16. Peppercorn JM, Weeks JC, Cook EF et al. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 2004 363: 263 270.
17. Weijer C, Freedman B, Fuks A et al. What difference does it make to be treated in a clinical trial? A pilot study. Clin Invest Med 1996 19: 179 183.
18. Schmidt B, Gillie P, Caco C et al. Do sick newborn infants benefit from participation in a randomized clinical trial J Pediatr 1999 134: 151 155.
19. Ondrusek N, Abramovitch R, Pencharz P et al. Empirical examination of the ability of children to consent to clinical research. J Med Ethics 1998 24: 158 165.
20. Barfield RC, Church C. Informed consent in pediatric clinical trials. Curr Opin Pediatr 2005 17: 20 24.
21. Koren G. Healthy children as subjects in pharmaceutical research. Theor Med Bioeth 2003 24: 149 159.
22. Humphrey GB, Boon CM, van Linden van den Heuvell GF et al. The occurrence of high levels of acute behavioral distress in children and adolescents undergoing routine venipunctures. Pediatrics 1992 90: 87 91.
23. Concorde. MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee. Lancet 1994 343: 871 881.
24. Volberding PA, Lagakos SW, Koch MA et al. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med 1990 322: 941 949.
25. Fischl MA, Richman DD, Hansen N et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med 1990 112: 727 737.
26. The cardiac arrhythmia suppression trial. N Engl J Med 1989 321: 1754 1756 1997 336: 525 533.
27. Bickell WH, Wall MJ Jr., Pepe PE et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994 331: 1105 1109.
28. Sprung CL, Caralis PV, Marcial EH et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984 311: 1137 1143.
29. Bernard GR, Luce JM, Sprung CL et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987 317: 1565 1570.
30. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000.
31. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987 317: 141 145.
32. Kearns GL. Impact of developmental pharmacology on pediatric study design: overcoming the challenges. J Allergy Clin Immunol 2000 106: S128 S138.
33. Tauer CA. Testing drugs in pediatric populations: the FDA mandate. Account Res 1999 7: 37 58.
34. Watson R. EU supports testing for children's drugs. BMJ 2005 330: 1348.
35. Ward RM. Children, drugs, and the Food and Drug Administration: studies of pediatric drugs are beginning to catch up. Pediatr Ann 2001 30: 189 194.
36. Committee on Drugs, American Academy of Pediatrics. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics 1995 95: 286 294.
37. Caldwell PH, Butow PN, Craig JC. Parents' attitudes to children's participation in randomized controlled trials. J Pediatr 2003 142: 554 559.
38. Caldwell PH, Murphy SB, Butow PN et al. Clinical trials in children. Lancet 2004 364: 803 811.
39. Mahon J, Laupacis A, Donner A et al. Randomised study of n of 1 trials versus standard practice. BMJ 1996 312: 1069 1074.
40. Nikles CJ, Yelland M, Glasziou PP et al. Do individualized medication effectiveness tests (n-of-1 trials) change clinical decisions about which drugs to use for osteoarthritis and chronic pain Am J Ther 2005 12: 92 97.
41. Helms PJ. 'Real world' pragmatic clinical trials: what are they and what do they tell us Pediatr Allergy Immunol 2002 13: 4 9.
42. Roland M, Torgerson DJ. What are pragmatic trials BMJ 1998 316: 285.
43. O'Rourke PP, Crone RK, Vacanti JP et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 1989 84: 957 963.
44. Torgerson DJ, Roland M. What is Zelen's design BMJ 1998 316: 606.
45. Biros MH. Research without consent: current status, 2003. Ann Emerg Med 2003 42: 550 564.
46. Chessells JM. Treatment of childhood acute lymphoblastic leukaemia: present issues and future prospects. Blood Rev 1992 6: 193 203.